Monsenso AS (MONSO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Monsenso AS (MONSO) has a cash flow conversion efficiency ratio of -0.309x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-2.16 Million ≈ $-337.32K USD) by net assets (Dkr6.98 Million ≈ $1.09 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Monsenso AS (MONSO) balance sheet quality index to measure how much of total assets are equity-financed.
Monsenso AS - Cash Flow Conversion Efficiency Trend (2016–2025)
This chart illustrates how Monsenso AS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Monsenso AS (MONSO) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Monsenso AS Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Monsenso AS ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GAS2GRID Ltd
AU:GGX
|
0.014x |
|
Twin Hospitality Group Inc.
NASDAQ:TWNP
|
0.064x |
|
iSpecimen Inc
NASDAQ:ISPC
|
-4.130x |
|
Toys R US ANZ Ltd
AU:TOY
|
0.426x |
|
Bubalus Resources Ltd
AU:BUS
|
-0.072x |
|
Cyanotech Corporation
NASDAQ:CYAN
|
-0.008x |
|
Akanda Corp
NASDAQ:AKAN
|
0.031x |
|
TTCL Public Company Limited
BK:TTCL
|
-0.119x |
Annual Cash Flow Conversion Efficiency for Monsenso AS (2016–2025)
The table below shows the annual cash flow conversion efficiency of Monsenso AS from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Monsenso AS worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | Dkr6.98 Million ≈ $1.09 Million |
Dkr-1.49 Million ≈ $-233.12K |
-0.214x | +56.98% |
| 2024-12-31 | Dkr14.16 Million ≈ $2.22 Million |
Dkr-7.03 Million ≈ $-1.10 Million |
-0.497x | -311.56% |
| 2023-12-31 | Dkr10.87 Million ≈ $1.70 Million |
Dkr2.55 Million ≈ $399.28K |
0.235x | +202.16% |
| 2022-12-31 | Dkr14.76 Million ≈ $2.31 Million |
Dkr-3.39 Million ≈ $-530.39K |
-0.230x | -12.40% |
| 2021-12-31 | Dkr21.44 Million ≈ $3.35 Million |
Dkr-4.38 Million ≈ $-685.75K |
-0.204x | -231.21% |
| 2020-12-31 | Dkr18.65 Million ≈ $2.92 Million |
Dkr2.91 Million ≈ $454.66K |
0.156x | +386.64% |
| 2019-12-31 | Dkr3.86 Million ≈ $604.55K |
Dkr-210.00K ≈ $-32.86K |
-0.054x | +91.70% |
| 2018-12-31 | Dkr3.82 Million ≈ $597.20K |
Dkr-2.50 Million ≈ $-390.99K |
-0.655x | -28.52% |
| 2017-12-31 | Dkr4.91 Million ≈ $767.42K |
Dkr-2.50 Million ≈ $-390.94K |
-0.509x | -32.62% |
| 2016-12-31 | Dkr6.51 Million ≈ $1.02 Million |
Dkr-2.50 Million ≈ $-390.94K |
-0.384x | -- |
About Monsenso AS
Monsenso A/S develops and sells digital health solution for the treatment of depression, bipolar disorder, anxiety, schizophrenia, borderline personality disorder, and addiction and substance abuse in Denmark. The company offers Monsenso app for individuals that collects patient-reported and sensor data providing insights into symptoms, adherence, and outcomes. It also provides Monsenso solution,… Read more